NCT07268768

Brief Summary

Headache, in its episodic and chronic forms, cannot be considered solely as an isolated neurological symptom, but as a complex condition of a bio-psycho-social nature. While in the episodic form the painful episodes occur intermittently and have a variable impact on daily life, in the chronic form the disease evolves towards persistent pain, with more significant consequences on personal, social and work functioning. The following study protocol aims to investigate in an integrated manner the neurological, cognitive and psychological mechanisms involved in headache, with particular attention to the differences between episodic and chronic forms. The main objective is to assess the neuropsychological profiles and pain response of patients, monitoring their evolution over a period of approximately six months, considering the impact of central sensitisation, personality structure and any psychopathological comorbidities on pain management and treatment adherence. The protocol adopts a multidimensional approach aimed at optimising therapeutic efficacy and improving patients' quality of life, preventing progression to chronicity.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P25-P50 for all trials

Timeline
30mo left

Started Nov 2025

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress19%
Nov 2025Nov 2028

Study Start

First participant enrolled

November 20, 2025

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

November 24, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 8, 2025

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 20, 2028

Last Updated

December 8, 2025

Status Verified

December 1, 2025

Enrollment Period

3 years

First QC Date

November 24, 2025

Last Update Submit

December 5, 2025

Conditions

Keywords

chronic migraine; central sensitization; cognitive impairment; personality disorders; treatment adherence; anxiety; depression;

Outcome Measures

Primary Outcomes (1)

  • Neuropsychological assessment

    •Cognitive functions: Brief Cognitive Status Exam (BCSE) and/or Montreal Cognitive Assessment (MoCA)

    6 months

Secondary Outcomes (1)

  • Central sensitization

    6 months

Study Arms (2)

Chronic headache

Patients suffering from chronic headache

Other: Neuropsychological assessment

Episodic headache

Patients suffering from episodic headache

Other: Neuropsychological assessment

Interventions

Standardized and ad hoc test battery for comprehensive neuropsychological assessment

Chronic headacheEpisodic headache

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The target population consists of adult patients with a diagnosis of chronic or episodic headache referring to the Headache Outpatient Clinic. Sample size was calculated using G\*Power 3.1, taking as reference the primary objective of comparing the evolution (baseline vs T1) of main clinical-neuropsychological outcomes between chronic and episodic headache groups. The primary test was modeled as a repeated-measures ANOVA on the group×time interaction (two groups, two measurements), analogous to the interaction component of a linear mixed model. With a significance level α = 0.05, statistical power 1-β = 0.90, intra-subject correlation r = 0.60 and two measurements, assuming an interaction effect size f = 0.20 and nonsphericity correction ε = 1, the minimum required sample size is N = 56 subjects (28 per group). Taking into account an expected dropout rate of 15%, the required enrollment was increased to N = 64 participants (32 per group), in order to preserve the planned power for the p

You may qualify if:

  • Age between 18 and 60 years;
  • Diagnosis of chronic or episodic headache;
  • Patients attending the Headache Outpatient Clinic.

You may not qualify if:

  • Presence of severe psychiatric and neurological disorders;
  • Presence of oncological diseases in terminal stage

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Irccs Centro Neurolesi Bonino Pulejo

Messina, Sicily, 98066, Italy

RECRUITING

MeSH Terms

Conditions

Bronchiolitis Obliterans SyndromeHeadache DisordersCognitive DysfunctionPersonality DisordersTreatment Adherence and ComplianceAnxiety DisordersDepression

Interventions

Neuropsychological Tests

Condition Hierarchy (Ancestors)

Organizing PneumoniaBronchiolitis ObliteransBronchiolitisBronchitisBronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesGraft vs Host DiseaseImmune System DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCognition DisordersNeurocognitive DisordersMental DisordersHealth BehaviorBehaviorBehavioral Symptoms

Intervention Hierarchy (Ancestors)

Psychological TestsBehavioral Disciplines and Activities

Central Study Contacts

Anna Anselmo, Psychologist

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Psychologist

Study Record Dates

First Submitted

November 24, 2025

First Posted

December 8, 2025

Study Start

November 20, 2025

Primary Completion (Estimated)

November 20, 2028

Study Completion (Estimated)

November 20, 2028

Last Updated

December 8, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations